Yuengling’s Ice Cream Corporation (OTC Pink: YCRM) was originally founded in 1920 by Frank D. Yuengling to help support the family’s beer business during the Prohibition. The ice cream business was spun off as a separate company in 1935 and continues to make its classic desserts in central Pennsylvania. Shares of the ice cream company are surging 81% through afternoon trading on Monday, December 12, 2022. Over the past thirty days, Yuengling’s Ice Cream Corporation has seen average daily volume of 68,643 shares. However, volume of 2.95 million shares or dollar volume of around $47,790, has already exchanged hands through afternoon trading.
Shares of Yuengling’s Ice Cream Corporation are surging after the company announced it has entered into an exclusive licensing agreement with GPO Plus, Inc. (OTCQB: GPOX) to create a full line of CBD and hemp-derived cannabinoid ice cream products under the Yuengling brand name. The partnership comes as Yuengling looks to re-launch its ice cream business in the spring of 2023.
The company says it will work with GPO Plus to derive hemp cannabinoids that are compliant under the 2019 Farm Bill, such as Delta 8, 9, 10, THC-o, THC-p, THC-x, THC-b, and more. The hemp cannabinoids will be sourced from GPO Plus’s DISTRO+ division, which uses only the highest quality ingredients. Yuengling and GPO Plus plan to provide additional details on products, flavors and launch date in an upcoming press release.
Brett H. Pojunis, CEO of GPOX stated: “I grew up in New York, where Yuengling’s is a household name and a very popular brand throughout the Northeast. I am beyond excited to partner with the Yuengling’s Ice Cream family and be tasked to develop the new CBD and Cannabinoid products for such a storied, well known legacy brand. We’re extremely excited about building out the sales channels, based on our complimentary geographic reach, and developing this new suite of products based on the Yuengling’s Ice Cream flavor profiles!”
Disclosure: No position. Spotlight Growth has no relationships with any of the companies mentioned in this article and did not receive payment in any form for its creation. This is an opinion article and is not meant to be financial advise. We are not broker-dealers or investment professionals. Please conduct your own due diligence. For more information on our disclosures, please visit: https://spotlightgrowth.com/disclosures/